← Evidence map

TrialPharmacoEconomics2002

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.

Ketan Sheth et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2002

2003

2004

2005

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

this paperpooled itcites it

Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma. | OpenQuestion